Lucid Diligence Brief: Triana Biomedicines $120M Series B for TRI-611 in ALK+ NSCLC
December 6, 2025Oncology,clinical trials,NSCLC,biopharma,Lucid Diligence Brief,payer access,venture financing,targeted protein degradation,molecular glues,CNS metastasesALK inhibitors
Lucid Diligence Brief: Triana Biomedicines $120M Series B for TRI-611 in ALK+…
SABCS 2025 Preview: Key Breast Cancer Highlights to Watch
December 5, 2025Our Insights,breast cancercarboplatin,precision oncology,Conference Previews,venetoclax,Metastatic Breast Cancer,Benign Breast Disease,Chemotherapy,Aromatase Inhibitors,Ovarian Function Suppression,Letrozole,Palbociclib,SABCS 2025
Get ready for SABCS25 with LucidQuest’s concise preview of the sessions…
Vaccines Today—December 5, 2025
December 5, 2025BioPharma and Tech News,DEMENTIAcancer vaccine,shingles vaccine,WHO,GC Biopharma,Vaccine news,varicella vaccine,pertussis,BPZE1,ILiAD Biotechnologies,Datar Cancer Genetics
This week’s vaccines update highlights key clinical findings, regulatory…
Respiratory Today—December 5, 2025
December 5, 2025biosimilars,gene therapy,astrazeneca,sanofi,RSV,COPD,Asthma,BioPharma and Tech News,pulmonary arterial hypertension,Respiratory Newscipla,Alpha-1 antitrypsin deficiency
This week’s respiratory update highlights major developments across RSV…
Public Health Today—5 December, 2025
December 5, 2025HIV,Depression,BioPharma and Tech News,obesity,METABOLIC HEALTH,Public Health News,adolescent mental health,broadly neutralizing antibodies,GLP-1 agonists,psychiatric geneticsbreast cancer genomics,nitrous oxide
This Public Health weekly update highlights new evidence shaping behavioural,…
ASH 2025 Preview: Key Hematology Highlights to Watch
December 5, 2025Our Insights,Multiple MyelomaSickle Cell Disease,Hodgkin Lymphoma,Acute Myeloid Leukemia,Large B-cell lymphoma,Conference Previews,B-cell acute lymphoblastic leukemia,American Society of Hematology,European Hematology Association,Diffuse large B-cell lymphoma,Chronic myeloid leukemia,Venous thromboembolism
ASH 2025 at a glance Get ready for ASH 2025 with LucidQuest’s concise preview.…
Public Health Video Recap—December 5, 2025
December 5, 2025Amgen,astrazeneca,Asthma,BioPharma and Tech News,rheumatoid arthritis,Tezepelumab,Artificial sweeteners,Public Health News,oral steroids,peptibody mRNA therapy,protein binder designadolescent smartphone exposure,pneumonia
This biweekly Public Health video recap brings together key advances across…
Lucid Diligence Brief: Paradigm to acquire Flatiron’s Clinical Research Business
December 5, 2025digital health,Oncology,clinical trials,reimbursement,real-world evidence,biopharma,Lucid Diligence Brief,payer access,diligence,EMR integrationCRO market
Lucid Diligence Brief: Paradigm to acquire Flatiron’s Clinical Research…
Rare Disease Video Recap—December 4, 2025
December 4, 2025MetabERN,European Health Data Space,novartis,Latus Bio,Spinal Muscular Atrophy,Kedrion,BioPharma and Tech News,EMA ODD,Friedreich’s ataxia,Neuronal ceroid lipofuscinosis type 2,Regeneron,Congenital aceruloplasminemia,EMD Serono,Solid Biosciences,Rare Disease News,generalized myasthenia gravis,Alpha-1 antitrypsin deficiency,Tessera Therapeutics,CORDCanada National Strategy for Drugs for Rare Diseases,Chiesi Rare Diseases
This biweekly Rare Disease Video Recap highlights regulatory designations,…
Cardiovascular Video Recap—December 4, 2025
December 4, 2025Ischemic heart disease,astrazeneca,bayer,merck,BioPharma and Tech News,HEART FAILURE,Atrial fibrillation,hypertension,stroke,Cardiovascular News,Myelodysplastic syndromes,Portuguese Society of Diabetology,Portuguese Society of CardiologyPULSAR Portugal,Siemens Healthineers
This Cardiovascular Video Recap covers mechanistic trial wins, national…
Cardiovascular Today—December 4, 2025
December 4, 2025astrazeneca,bayer,BioPharma and Tech News,hypertension,Ischemic Stroke,Baxdrostat,Cardiovascular News,Intracranial atherosclerosis,Coronary artery calcium,AsundexianTranscatheter edge-to-edge repair (TEER),Cardiovascular imaging
This week’s cardiovascular update brings together new clinical signals, imaging…
Rare Disease Today—December 4, 2025
December 4, 2025real world data,artificial intelligence,gene therapy,BioPharma and Tech News,Rare Kidney Disease,Friedreich’s ataxia,Alexander disease,Rare Disease News,Regeneron Pharmaceuticals,CLN2 diseaseAlpha-1 antitrypsin deficiency,Ionis Pharmaceuticals
This week’s rare disease update highlights key regulatory designations, early…








